New coronavirus clinical trial will test repurposed drugs on patients in more than a dozen countries

Noted: Plasma trials have received FDA approval and are already moving forward at medical centers including those affiliated with Johns Hopkins University and University of Wisconsin-Madison. The FDA has also approved the use of survivor plasma to treat patients on an experimental, compassionate basis.